ClinicalTrialsFinder

Chronic Lymphocytic Leukemia Clinical Trials in Mönchengladbach, North Rhine-Westphalia

1 recruitingMönchengladbach, North Rhine-Westphalia, Germany

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Merck Sharp & Dohme LLC1,200 enrolled195 locationsNCT06136559